US Diabetes Treatment Costs Hit $153B in 2021-2022 Driving Medicare and Private Payer Expenses
In 2021-2022, diabetes treatment costs in the U.S. totaled $153.2 billion, driven largely by Medicare and private insurance coverage, according to AHRQ MEPS data.